Archiv

• 2022-03-28 Regulatory

  NeoDynamics announces outcome of rights issue

  Weiterlesen

• 2022-03-15 Non-regulatory

  NeoDynamics sets up NeoDynamics USA Inc.

  Weiterlesen

• 2022-03-01 Non-regulatory

  NeoDynamics has filed for registration of NeoNavia® in the US

  Weiterlesen

• 2022-02-25 Regulatory

  Communique from extraordinary general meeting in NeoDynamics AB (publ)

  Weiterlesen

• 2022-02-16 Non-regulatory

  NeoDynamics to present Q4 report on Feb 21 at 12.30

  Weiterlesen

• 2022-02-16 Regulatory

  NeoDynamics AB (publ) full-year report 2021

  Weiterlesen

• 2022-02-09 Regulatory

  Notice of extraordinary general meeting in NeoDynamics AB

  Weiterlesen

• 2022-01-24 Non-regulatory

  Interview and company presentation in collaboration with Uddaaktier

  Weiterlesen

• 2022-01-20 Non-regulatory

  New data from NeoDynamics PULSE study accepted for presentation at major US breast imaging conference

  Weiterlesen

• 2022-01-17 Non-regulatory

  NeoDynamics to present at Redeye Fight Cancer Seminar 20 Jan 2022

  Weiterlesen

• 2021-11-24 Non-regulatory

  NeoDynamics appoints Aaron Wong as CFO

  Weiterlesen

• 2021-11-17 Regulatory

  Interim report Q3 2021

  Weiterlesen

• 2021-11-15 Non-regulatory

  NeoDynamics presents Q3 report

  Weiterlesen

• 2021-11-08 Non-regulatory

  NeoDynamics presents first results from PULSE study

  Weiterlesen

• 2021-10-28 Non-regulatory

  NeoDynamics starts subsidiary in Germany

  Weiterlesen

• 2021-09-17 Non-regulatory

  NeoDynamics confirms four orders for NeoNavia

  Weiterlesen

• 2021-09-13 Non-regulatory

  NeoDynamics demonstrates NeoNavia live at congresses

  Weiterlesen

• 2021-08-25 Regulatory

  NeoDynamics granted a U.S. patent for its biopsy needle

  Weiterlesen

• 2021-08-19 Regulatory

  Interim report Jan-June 2021

  Weiterlesen

• 2021-07-09 Non-regulatory

  NeoDynamics receives first German order of pulse biopsy system NeoNavia

  Weiterlesen

• 2021-05-31 Non-regulatory

  NeoDynamics presents at Redeye Growth Day 2021

  Weiterlesen

• 2021-05-19 Regulatory

  First quarter - Introduction underway

  Weiterlesen

• 2021-05-17 Non-regulatory

  NeoDynamics presents an abstract on pulse biopsy data for NeoNavia at the UK Association of Breast Surgeons Conference 2021

  Weiterlesen

• 2021-04-27 Non-regulatory

  Matthew E. Colpoys, Jr. nominated to the Board of Directors

  Weiterlesen

• 2021-03-17 Non-regulatory

  NeoDynamics presents preclinical results today

  Weiterlesen

• 2021-03-15 Non-regulatory

  Invitation - NeoDynamics presents preclinical results on March 17 at 13.00 CET

  Weiterlesen

• 2021-02-17 Regulatory

  NeoDynamics AB (publ) Full year report 2020

  Weiterlesen

• 2021-01-14 Non-regulatory

  NeoDynamics will be granted another European patent for its pulse biopsy tools

  Weiterlesen

• 2020-11-19 Regulatory

  NeoDynamics AB (publ) Third Quarter 2020

  Weiterlesen

• 2020-11-19 Regulatory

  NeoDynamics receives first UK order of pulse biopsy system NeoNavia

  Weiterlesen

• 2020-11-12 Non-regulatory

  NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis

  Weiterlesen

• 2020-11-02 Regulatory

  Jörgen Vrenning is retiring as CFO of NeoDynamics

  Weiterlesen

• 2020-10-21 Regulatory

  NeoDynamics carries out directed new share issue of approximately SEK 90 million and convenes extraordinary general meeting

  Weiterlesen

• 2020-10-21 Regulatory

  NeoDynamics announces intention to carry out a directed share issue of approximately 24 million shares and intention to call for Extraordinary General Meeting

  Weiterlesen

• 2020-09-25 Non-regulatory

  NeoDynamics is approaching launch of new pulse biopsy system NeoNavia - reputed international gynecologists and radiologists gained positive hands-on experience

  Weiterlesen

• 2020-08-21 Regulatory

  NeoDynamics AB (publ) Half year report 2020

  Weiterlesen

• 2020-07-06 Regulatory

  NeoDynamics establishes reference centres in Germany to support the introduction of its novel pulse biopsy system NeoNavia and optimize the diagnosis of breast cancer

  Weiterlesen

• 2020-07-06 Regulatory

  NeoDynamics restarts patient recruitment to UK COMPULSE Study to optimize diagnosis of breast cancer

  Weiterlesen

• 2020-05-26 Regulatory

  NeoDynamics AB (publ) First Quarter 2020

  Weiterlesen

• 2020-02-05 Regulatory

  NeoDynamics AB (publ) full-year report 2019

  Weiterlesen

• 2020-02-03 Non-regulatory

  A clinical study performed at Karolinska Hospital with NeoDynamics’ new biopsy system, NeoNavia, has been accepted as an abstract by the Society for Breast Imaging (SBI) in the US.

  Weiterlesen

• 2020-01-28 Non-regulatory

  NeoDynamics AB (publ) receives notification of granted patent on biopsy instrument in China

  Weiterlesen

• 2019-11-27 Non-regulatory

  NeoDynamics signs manufacturing agreement for NeoNavia

  Weiterlesen

• 2019-11-21 Regulatory

  NeoDynamics AB (publ) Third quarter Jul-Sep 2019

  Weiterlesen

• 2019-11-05 Non-regulatory

  For the first time in UK, a wider audience can get first-hand experience of the NeoNavia® micropulse biopsy system for breast cancer

  Weiterlesen

• 2019-10-29 Regulatory

  NeoDynamics receives regulatory approval for new breast cancer biopsy system

  Weiterlesen

• 2019-09-16 Non-regulatory

  NeoDynamics recruits a country manager for Germany, Switzerland and Austria

  Weiterlesen

• 2019-08-28 Regulatory

  NeoDynamics has secured financing through the issue of convertibles and calls for an Extraordinary General Meeting

  Weiterlesen

• 2019-08-28 Regulatory

  NeoDynamics Half-year report 2019

  Weiterlesen

• 2019-08-15 Non-regulatory

  New date for NeoDynamics semi-annual report 2019

  Weiterlesen

• 2019-05-22 Regulatory

  NeoDynamics AB (publ) invests in biopsy instrument for more effective sampling of suspected skin cancer

  Weiterlesen

• 2019-05-21 Regulatory

  NeoDynamics AB (publ) - Quarterly report January-March 2019

  Weiterlesen

• 2019-04-26 Regulatory

  NeoDynamics AB (publ) receives advance notice from U.S. Patent Office for a granted biopsy instrument patent

  Weiterlesen

• 2019-04-10 Non-regulatory

  New breast biopsy device is evaluated at Karolinska University Hospital in Stockholm

  Weiterlesen

• 2019-02-21 Regulatory

  Year-end report 2018 - NeoDynamics

  Weiterlesen

• 2019-02-18 Non-regulatory

  New Swedish technology for breast cancer diagnosis tested by leading experts in Germany

  Weiterlesen

• 2018-12-07 Non-regulatory

  NeoNavia commercial version fully integrated according to plan

  Weiterlesen

• 2018-12-07 Non-regulatory

  First day of trading in NeoDynamics’ shares and warrants on Spotlight Stock Market

  Weiterlesen

• 2018-11-19 Regulatory

  NeoDynamics’ issue of units prior to planned listing on Spotlight Stock Market fully subscribed

  Weiterlesen

• 2018-11-12 Non-regulatory

  NeoDynamics participates on Stora Aktiedagen and in a Live Session with Småbolagsjakten today

  Weiterlesen

• 2018-11-06 Non-regulatory

  NeoDynamics participates in investor meetings during the IPO

  Weiterlesen

• 2018-11-06 Non-regulatory

  NeoDynamics introduces NeoNavia®, a micropulse biopsy system, to a wider audience in the UK

  Weiterlesen

• 2018-11-01 Non-regulatory

  New technology from NeoDynamics approved for study in Germany

  Weiterlesen

• 2018-10-31 Regulatory

  The subscription period in NeoDynamics’ issue of units prior to planned listing on Spotlight Stock Market begins today

  Weiterlesen

• 2018-10-30 Regulatory

  NeoDynamics AB (publ) announces approval on passportation of prospectus

  Weiterlesen

• 2018-10-29 Regulatory

  NeoDynamics AB (publ) publishes prospectus and enters agreement on additional subscription commitment

  Weiterlesen

• 2018-10-25 Regulatory

  NeoDynamics AB (publ) approved for listing on Spotlight Stock Market

  Weiterlesen